Painting with a molecular brush: Genomic/proteomic interfacing to define the drug action profile of novel solid-tumor selective anticancer agents

Cytometry

Volumn 47, Issue 1, 2002, Pages 72-79

  Nakeff, Alexander ^a   Sahay, Nisha ^b   Pisano, Mike ^b   Subramanian, Balanehru ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b Genomic Solutions Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEOME; QUINOXALINE DERIVATIVE; TUMOR PROTEIN; XK 469;

ADENOCARCINOMA; COLON TUMOR; GENE EXPRESSION PROFILING; GENETICS; HUMAN; MULTIGENE FAMILY; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; COLONIC NEOPLASMS; GENE EXPRESSION PROFILING; HUMANS; MAP KINASE SIGNALING SYSTEM; MULTIGENE FAMILY; NEOPLASM PROTEINS; PROTEOME; QUINOXALINES;

EID: 33748679338     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/cyto.10038     Document Type: Article

References (0)